Medical interventions may also be appropriate: Discuss antacid therapy with your GP : If reflux appears to be contributing, medications such as proton pump inhibitors (e.g., omeprazole) or H2-receptor antagonists (e.g., famotidine) may help, though these should only be used under medical supervision
The analysis of repeated treatment in the ExA study showed no significant effect of LIR treatment on active responding (F1,70 = 0.46, p = 0.499), inactive responding (F1,70 = 3.60, p = 0.062), daily (F1,70 = 2.11, p = 0.151), or cumulative METH intake (F1,70 = 2.33, p = 0.131)
FDA regulatory status - compounded GLP-1s: FDA proposed April 30, 2026 to exclude semaglutide and tirzepatide from 503B Bulks List
Eli Lilly, Rivus Pharmaceuticals and more target different biological processes in hopes of generating higher-quality weight loss and avoiding metabolic issues
98.7% Impressive